ITMCTR1900002280
Not yet recruiting
Phase 1
A Clinical Study for the Treatment of Parkinson's Disease with Integrated Shi Shi Tonifying Kidney Pill and Xingnao Kaiqiao Acupuncture
ShenZhen JinFangZhenLue Technology Ltd. Co.0 sitesTBD
ConditionsParkinson's disease
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Parkinson's disease
- Sponsor
- ShenZhen JinFangZhenLue Technology Ltd. Co.
- Status
- Not yet recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •(1\) diagnosis of Parkinsons disease according to the UK Parkinsons Disease Society Brain Bank Clinical Diagnostic Criteria;
- •(2\) the Hoehn\-Yahr (H\&Y) stage belongs to 1\-4;
- •(3\) aged between 40 and 80 years;
- •(4\) the course of PD is \=6 months;
- •(5\) those who voluntarily participate in the study, receive relevant examinations and treatments, and sign informed consent.
Exclusion Criteria
- •(1\) acute cerebral infarction patients;
- •(2\) women who were pregnant or lactating and women of child\-bearing age did not take contraceptive measures;
- •(3\) complicated with serious liver and kidney dysfunction, mental illness or hematopoietic system diseases;
- •(4\) the infection of the skin near the acupuncture point or acupoint;
- •Note: any patient who meets any of the above shall be excluded.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Clinical observation on the treatment of Parkinson's disease with fatigue by three injectionsParkinson's disease fatigueITMCTR2200006777The First Affiliated Hospital of Guangzhou University of Chinese Medicine
Not yet recruiting
Not Applicable
A Clinical study of Parkinsonâ??s disease and comparativr evaluation of two unani formulations (Combination of jadwar and ood e saleeb with majoon e jograj gogul) in its management.Health Condition 1: G328- Other specified degenerative disorders of nervous system in diseases classified elsewhereHealth Condition 2: G328- Other specified degenerative disorders of nervous system in diseases classified elsewhereCTRI/2021/09/036722Department of Moalejat
Completed
Not Applicable
Study about perception of Parkinson's disease progression among patients with Parkinson's disease and physicians in JapaJPRN-UMIN000032542AbbVie GK210
Completed
Phase 3
The INVEST study Treatment in advanced Parkinson’s disease: continuous intrajejunal levodopa INfusion VErsus deep brain STimulation.<p>advanced Parkinson's disease, gevorderde ziekte van Parkinson</p>10028037NL-OMON21505ZonMw66
Recruiting
Phase 1
Phase I/II Study of Gene Therapy for Parkinson's diseaseJPRN-jRCT2033210696akajima Takeshi12